SKI Market

A+| A| A-|

Indian Indices

Sensex

75,977.32 -32.38
( -0.04%)

Global Indices

Nasdaq

50,493.86 -106.84
(-0.21%)

Dow Jones

7,540.47 46.00
(0.61%)

Hang Seng

64,932.04 -226.15
(-0.35%)

Nikkei 225

10,499.42 33.16
(0.32%)

Forex

USD-INR

95.26 -0.35
(-0.37%)

EUR-INR

110.89 -0.08
(-0.07%)

GBP-INR

128.53 0.11
(0.08%)

JPY-INR

0.60 0.00
(-0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

291.9817605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

39.81

39988.86

EPS(TTM)

Face Value()

Div & Yield %

39.59

0.25

Back

Cybele Industries reports consolidated net profit of Rs 6.16 crore in the December 2025 quarter

Feb 14,2026

Net profit of Cybele Industries reported to Rs 6.16 crore in the quarter ended December 2025 as against net loss of Rs 2.02 crore during the previous quarter ended December 2024. Sales rose 142.74% to Rs 15.22 crore in the quarter ended December 2025 as against Rs 6.27 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	15.22	6.27	143
OPM %	-7.29	-24.40	-
PBDT	6.04	-1.76	LP
PBT	6.25	-1.97	LP
NP	6.16	-2.02	LP

75,977.32 -32.38 ( -0.04%)

50,493.86 -106.84 (-0.21%)

7,540.47 46.00 (0.61%)

64,932.04 -226.15 (-0.35%)

10,499.42 33.16 (0.32%)

95.26 -0.35 (-0.37%)

110.89 -0.08 (-0.07%)

128.53 0.11 (0.08%)

0.60 0.00 (-0.21%)